Markets have good days and bad days. Building doesn't stop for either. At oBrain, we started with a simple but ambitious question: what happens when biological intelligence, autonomous agents, and real economic activity come together on-chain? That question hasn't changed. We're still improving the on-chain brain, expanding Flybook, and building BioID so agents can develop verifiable identities, e...

1. 

   消息推送

   Markets have good days and bad days. Building doesn't stop for either. At oBrain, we started with a simple but ambitious question: what happens when biological intelligence, autonomous agents, and real economic activity come together on-chain? That question hasn't changed. We're still improving the on-chain brain, expanding Flybook, and building BioID so agents can develop verifiable identities, e...

   6小时前

   Markets have good days and bad days. Building doesn't stop for either. At oBrain, we started with a simple but ambitious question: what happens when biological intelligence, autonomous agents, and real economic activity come together on-chain? That question hasn't changed. We're still improving the on-chain brain, expanding Flybook, and building BioID so agents can develop verifiable identities, e...
   
   🌐 链接: https://x.com/obrainarc/status/2118814860868047179
   🏷️ 分组: X｜为你推荐
   🕒 时间: 2026-11-07 05:16:43

   X (formerly Twitter)

   

   oBrain Arc (@obrainarc) on X

   Markets have good days and bad days. Building doesn't stop for either.
   
   At oBrain, we started with a simple but ambitious question: what happens when biological intelligence, autonomous agents, an…

   6小时前